2008
DOI: 10.1186/bcr1851
|View full text |Cite
|
Sign up to set email alerts
|

The combined immunodetection of AP-2α and YY1 transcription factors is associated with ERBB2 gene overexpression in primary breast tumors

Abstract: Introduction Overexpression of the ERBB2 oncogene is observed in about 20% of human breast tumors and is the consequence of increased transcription rates frequently associated with gene amplification. Several studies have shown a link between activator protein 2 (AP-2) transcription factors and ERBB2 gene expression in breast cancer cell lines. Moreover, the Yin Yang 1 (YY1) transcription factor has been shown to stimulate AP-2 transcriptional activity on the ERBB2 promoter in vitro. In this report, we examine… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

4
89
1

Year Published

2009
2009
2021
2021

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 97 publications
(98 citation statements)
references
References 30 publications
4
89
1
Order By: Relevance
“…The putative role of YY1 in tumorigenesis is supported by its known interaction in the cell cycle regulation 4 and, accordingly, many studies were conducted to evaluate the involvement of YY1 in several solid tumor types. [14][15][16][17][18][19] In this study we have provided evidence that YY1 is expressed at significantly higher levels in high-grade lymphomas, including Burkitt's Lymphoma and DLBCL, when compared to normal B cells. DLBCL is the most frequent non-Hodgkin's lymphoma subtype, accounting for 30% to 35% of all lymphoma cases.…”
Section: Discussionmentioning
confidence: 82%
“…The putative role of YY1 in tumorigenesis is supported by its known interaction in the cell cycle regulation 4 and, accordingly, many studies were conducted to evaluate the involvement of YY1 in several solid tumor types. [14][15][16][17][18][19] In this study we have provided evidence that YY1 is expressed at significantly higher levels in high-grade lymphomas, including Burkitt's Lymphoma and DLBCL, when compared to normal B cells. DLBCL is the most frequent non-Hodgkin's lymphoma subtype, accounting for 30% to 35% of all lymphoma cases.…”
Section: Discussionmentioning
confidence: 82%
“…Transcription factors such as AP-2 (8), YY1 (20), ETS (21), YB-1 (22), and EGR2 (23) have been shown to be recruited to the promoter of ERBB2 and play a role in its overexpression in breast cancer cells. Therefore, understanding the mechanisms governing the repressive and positive regulation of ERBB2 expression and its neighboring genes in the amplified locus is of considerable importance in identifying the transcription factors and molecular events involved in the establishment of ERBB2-positive tumors.…”
Section: Introductionmentioning
confidence: 99%
“…Girdin has been reported to be highly expressed in invasive colon and breast carcinoma tissues, and high levels of Girdin expression correlate significantly with ErbB2 oncogene expression in breast cancer (Garcia-Marcos et al, 2011;Jiang et al, 2008;Ling et al, 2011). Interestingly, ErbB2 expression is also transcriptionally regulated by AP-2α and is associated with AP-2α in breast cancer (Allouche et al, 2008;Bosher et al, 1995;Pellikainen et al, 2004). Therefore, it is possible that accumulated genetic and epigenetic mutations during cancer progression might deregulate PAR-3, leading to aberrant transcriptional activity and/or increased expression of AP-2α, and resulting in Girdin and ErbB2 overexpression.…”
Section: Biological Implications Of the Par-3-ap-2-girdin Pathway Inmentioning
confidence: 90%